Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Suisse (CSUI) Shares Outstanding (Diluted Average) (2016 - 2026)

Cannabis Suisse (CSUI) has disclosed Shares Outstanding (Diluted Average) for 11 consecutive years, with $208.3 million as the latest value for Q1 2026.

  • For Q1 2026, Shares Outstanding (Diluted Average) rose 5.07% year-over-year to $208.3 million; the TTM value through Feb 2026 reached $208.3 million, up 5.07%, while the annual FY2020 figure was $35.5 million, 31.62% down from the prior year.
  • Shares Outstanding (Diluted Average) was $208.3 million for Q1 2026 at Cannabis Suisse, up from $205.9 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $208.3 million in Q1 2026, with the low at $31.1 million in Q1 2022.
  • Historically, Shares Outstanding (Diluted Average) has averaged $133.9 million across 5 years, with a median of $195.8 million in 2024.
  • The largest annual shift saw Shares Outstanding (Diluted Average) decreased 9.88% in 2022 before it soared 334.76% in 2024.
  • Over 5 years, Shares Outstanding (Diluted Average) stood at $31.1 million in 2022, then soared by 44.87% to $45.0 million in 2023, then soared by 334.76% to $195.8 million in 2024, then grew by 5.14% to $205.9 million in 2025, then rose by 1.2% to $208.3 million in 2026.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $208.3 million in Q1 2026, $205.9 million in Q4 2025, and $203.5 million in Q3 2025.